Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis

Trial Profile

Phase II trial of nitric oxide in patients with respiratory syncytial virus and bronchiolitis

Recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2015

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Bronchiolitis; Respiratory syncytial virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Apr 2015 Data will be presented at the American Thoracic Society 2015 International Conference, according to an Advanced Inhalation Therapies media release.
    • 21 Apr 2015 Updated data will be presented at the European Society of Pediatric Infectious Disease 2015, according to a Advanced Inhalation Therapies media release.
    • 07 Jan 2014 This trial is continuing, according to an AIT media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top